<VariationArchive RecordType="classified" VariationID="623145" VariationName="NM_000424.4(KRT5):c.817del (p.Phe272_Val273insTer)" VariationType="Deletion" Accession="VCV000623145" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-04-25" DateCreated="2019-03-24" MostRecentSubmission="2021-10-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="612096" VariationID="623145">
      <GeneList>
        <Gene Symbol="KRT5" FullName="keratin 5" GeneID="3852" HGNC_ID="HGNC:6442" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="52514575" stop="52520394" display_start="52514575" display_stop="52520394" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="52908358" stop="52914242" display_start="52908358" display_stop="52914242" Strand="-" />
          </Location>
          <OMIM>148040</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000424.4(KRT5):c.817del (p.Phe272_Val273insTer)</Name>
      <CanonicalSPDI>NC_000012.12:52518116:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q13.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="52518117" stop="52518117" display_start="52518117" display_stop="52518117" variantLength="1" positionVCF="52518116" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="52911901" stop="52911901" display_start="52911901" display_stop="52911901" variantLength="1" positionVCF="52911900" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.52911901del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.52911901del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.52518117del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.52518117del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008297.1" sequenceAccession="NG_008297" sequenceVersion="1" change="g.7343del">
            <Expression>NG_008297.1:g.7343del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000424.4" sequenceAccession="NM_000424" sequenceVersion="4" change="c.817del" MANESelect="true">
            <Expression>NM_000424.4:c.817del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000415.2" sequenceAccession="NP_000415" sequenceVersion="2" change="p.Phe272_Val273insTer">
            <Expression>NP_000415.2:p.Phe272_Val273insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="148040.0022" DB="OMIM" />
        <XRef Type="rs" ID="1565593355" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000424.4(KRT5):c.817del (p.Phe272_Val273insTer) AND Epidermolysis bullosa simplex" Accession="RCV000761247" Version="1">
        <ClassifiedConditionList TraitSetID="9444">
          <ClassifiedCondition DB="MedGen" ID="C0079298">Epidermolysis bullosa simplex</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-04-13" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000424.4(KRT5):c.817del (p.Phe272_Val273insTer) AND EPIDERMOLYSIS BULLOSA SIMPLEX 2D, GENERALIZED SEVERE, AUTOSOMAL RECESSIVE" Accession="RCV001759447" Version="1">
        <ClassifiedConditionList TraitSetID="70312">
          <ClassifiedCondition>EPIDERMOLYSIS BULLOSA SIMPLEX 2D, GENERALIZED SEVERE, AUTOSOMAL RECESSIVE</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-10-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-04-13" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2019-03-24" MostRecentSubmission="2021-10-30">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16465624</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20199538</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31312705</ID>
        </Citation>
        <DescriptionHistory Dated="2021-11-05">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-11-05">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="70312" Type="Disease">
            <Trait ID="57574" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">EPIDERMOLYSIS BULLOSA SIMPLEX 2D, GENERALIZED SEVERE, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="Allelic variant" ID="148040.0022" DB="OMIM" />
                <XRef Type="Allelic variant" ID="148040.0024" DB="OMIM" />
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9444" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9491" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa simplex</ElementValue>
                <XRef ID="MONDO:0017610" DB="MONDO" />
                <XRef ID="67144006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa simplex, Weber-Cockayne type (subtype)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa simplex, Dowling-Meara type (subtype)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa simplex with mottled pigmentation (subtype)</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Epidermolysis bullosa simplex (EBS) is characterized by fragility of the skin (and mucosal epithelia in some cases) that results in non-scarring blisters and erosions caused by minor mechanical trauma. The current classification of epidermolysis bullosa (EB) includes two major types and 17 minor subtypes of EBS; all share the common feature of blistering above the dermal-epidermal junction at the ultrastructural level. The four most common subtypes of EBS are the focus of this GeneReview: EBS, localized (EBS-loc; previously known as Weber-Cockayne type). EBS, generalized intermediate (EBS-gen intermed; previously known as Koebner type). EBS-with mottled pigmentation (EBS-MP). EBS, generalized severe (EBS-gen sev; previously known as Dowling-Meara type). The phenotypes for these subtypes range from relatively mild blistering of the hands and feet to more generalized blistering, which can be fatal. In EBS-loc, blisters are rarely present or minimal at birth and may occur on the knees and shins with crawling or on the feet at approximately age 18 months; some individuals manifest the disease in adolescence or early adulthood. Blisters are usually confined to the hands and feet, but can occur anywhere if trauma is significant. In EBS, gen intermed, blisters may be present at birth or develop within the first few months of life. Involvement is more widespread than in EBS-loc, but generally milder than in EBS-gen sev. In EBS-MP, skin fragility is evident at birth and clinically indistinguishable from EBS-gen sev; over time, progressive brown pigmentation interspersed with hypopigmented spots develops on the trunk and extremities, with the pigmentation disappearing in adult life. Focal palmar and plantar hyperkeratoses may occur. In EBS-gen sev, onset is usually at birth; severity varies greatly, both among and within families. Widespread and severe blistering and/or multiple grouped clumps of small blisters are typical and hemorrhagic blisters are common. Improvement occurs during mid- to late childhood. Progressive hyperkeratosis of the palms and soles begins in childhood and may be the major complaint of affected individuals in adult life. Nail dystrophy and milia are common. Both hyper- and hypopigmentation can occur. Mucosal involvement in EBS-gen sev may interfere with feeding, especially in neonates and infants. Blistering can be severe enough to result in neonatal or infant death.</Attribute>
                <XRef ID="NBK1369" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10752" />
                <XRef ID="10752" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301543</ID>
                <ID Source="BookShelf">NBK1369</ID>
              </Citation>
              <XRef ID="304" DB="Orphanet" />
              <XRef ID="C0079298" DB="MedGen" />
              <XRef ID="MONDO:0017610" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS131760" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1747003" SubmissionDate="2018-11-11" DateLastUpdated="2019-03-24" DateCreated="2019-03-24">
        <ClinVarSubmissionID localKey="NM_000424.3:c.817delG" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000891203" DateUpdated="2019-03-24" DateCreated="2019-03-24" Type="SCV" Version="1" SubmitterName="Molecular Diagnostics Laboratory, M Health Fairview: University of Minnesota" OrgID="506641" OrganizationCategory="laboratory" OrgAbbreviation="UMMC-MDL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20199538</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16465624</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KRT5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Val273X</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000424.3:c.817delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Epidermolysis bullosa simplex</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4781723</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3881889" SubmissionDate="2021-10-28" DateLastUpdated="2021-10-30" DateCreated="2021-10-30">
        <ClinVarSubmissionID localKey="148040.0022_EPIDERMOLYSIS BULLOSA SIMPLEX 2D, GENERALIZED SEVERE, AUTOSOMAL RECESSIVE" title="KRT5, 1-BP DEL, 817G_EPIDERMOLYSIS BULLOSA SIMPLEX 2D, GENERALIZED SEVERE, AUTOSOMAL RECESSIVE" />
        <ClinVarAccession Accession="SCV001985067" DateUpdated="2021-10-30" DateCreated="2021-10-30" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-28">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 2-year-old boy with severe autosomal recessive EBS (EBS2D; 619599), Tryon et al. (2019) detected homozygosity for a c.817delG deletion in the KRT5 gene that resulted in premature termination of the protein (val273-to-ter, V273X) in the 1B domain. The unaffected parents and brother were heterozygous for the mutation. Immunofluorescence staining of a full-thickness skin biopsy from the patient showed normal staining for collagens VII (see 120120) and XVII (113811) and laminins A3 (600805), B3 (150310), and C2 (150292). However, the epidermis was thin, with discontinuous sparse staining for keratin-5 and -14 (148066). Immunoelectron microscopy showed disorganization of cytoplasmic contents of basal keratinocytes and mostly absent intermediate filaments. The patient died at 26 months of age.</Attribute>
              <Citation>
                <ID Source="PubMed">31312705</ID>
              </Citation>
              <XRef DB="OMIM" ID="619599" Type="MIM" />
              <XRef DB="OMIM" ID="120120" Type="MIM" />
              <XRef DB="OMIM" ID="113811" Type="MIM" />
              <XRef DB="OMIM" ID="600805" Type="MIM" />
              <XRef DB="OMIM" ID="150310" Type="MIM" />
              <XRef DB="OMIM" ID="150292" Type="MIM" />
              <XRef DB="OMIM" ID="148066" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KRT5" />
          </GeneList>
          <Name>KRT5, 1-BP DEL, 817G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 817G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="148040.0022" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPIDERMOLYSIS BULLOSA SIMPLEX 2D, GENERALIZED SEVERE, AUTOSOMAL RECESSIVE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3881889" TraitType="Disease" MappingType="Name" MappingValue="EPIDERMOLYSIS BULLOSA SIMPLEX 2D, GENERALIZED SEVERE, AUTOSOMAL RECESSIVE" MappingRef="Preferred">
        <MedGen CUI="None" Name="EPIDERMOLYSIS BULLOSA SIMPLEX 2D, GENERALIZED SEVERE, AUTOSOMAL RECESSIVE" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1747003" TraitType="Disease" MappingType="Name" MappingValue="Epidermolysis bullosa simplex" MappingRef="Preferred">
        <MedGen CUI="C0079298" Name="Epidermolysis bullosa simplex" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

